Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

APOTEX

  • FDA Approval
  • Aug. 22, 2023, 11:50 UTC
  • 33
  • 0 comments

FDA approve PAROXETINE HYDROCHLORIDE

Comment Full text

APOTEX

  • FDA Approval
  • Aug. 22, 2023, 11:50 UTC
  • 34
  • 0 comments

FDA approve PAROXETINE HYDROCHLORIDE

Comment Full text

ELI LILLY AND CO

  • FDA Approval
  • Aug. 22, 2023, 11:50 UTC
  • 34
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Aug. 22, 2023, 11:50 UTC
  • 54
  • 0 comments

FDA approve DROSPIRENONE; ETHINYL ESTRADIOL

Comment Full text

GLOBAL BLOOD THERAPS

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 51
  • 0 comments

FDA approve VOXELOTOR

Comment Full text

NEUROCRINE

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 48
  • 0 comments

FDA approve VALBENAZINE TOSYLATE

Comment Full text

REGENERON PHARMACEUTICALS

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 36
  • 0 comments

FDA approve POZELIMAB-BBFG

Comment Full text

ABBVIE

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 52
  • 0 comments

FDA approve LEVOMILNACIPRAN HYDROCHLORIDE

Comment Full text

ALEMBIC PHARMS LTD

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 55
  • 0 comments

FDA approve DESVENLAFAXINE

Comment Full text

ALMATICA

  • FDA Approval
  • Aug. 22, 2023, 11:03 UTC
  • 52
  • 0 comments

FDA approve SERTRALINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 705
  • 706
  • 707
  • 708
  • 709
  • Next

Search

News categories

  • Technical Exchange News(13236)
  • Event(6229)
  • SEC News(335527)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(186556)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin